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Abstract 
Background: Older people represent a sizeable population of the UK. Many older people 
receive drug treatment for long term conditions. Adherence with medication is therefore 
an important clinical, financial and resource intensive concern.  
Objectives: This review aimed to examine patient’s beliefs, perceptions and views in 
relation  to adherence with  medication. 
Design: A comprehensive search of the literature was undertaken using numerous 
approaches.  The search of revealed 30 research papers.  
Findings: Articles were initially evaluated using Critical Appraisal Skills Programme 
principles to identify those relevant to the review. Relevant studies were then subjected to 
a narrative analysis to assist the development of relevant themes. Four themes were 
identified; experience of adherence; perceptions and attitudes to medication adherence 
and non-adherence; patients acceptance of their illness and impact on medication taking 
behaviour and shared decision making. 
Conclusions:  The findings of this review imply that there is a need for more emphasis on 
shared decision making between the older patient and the prescriber. Using this approach 
adherence with medication may improve. There is also a need to develop a standardized 
measure of medication adherence.  
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What is already known about the topic? 
 
• In England the majority of medicines are prescribed for older people 
• Older people are increasingly likely to mismanage their medicines  
• In older people medication taking behaviour can vary due to the effects of ageing, 
illness and social reasons. 
 
What this paper adds? 
• There is no gold standard for measuring adherence with medication. 
• Two forms of non-adherence are acknowledged; intentional non-adherence and 
unintentional non-adherence. Older people can concurrently exhibit both forms. 
• In older people perceptions of illness and poor comprehension of the role of 
medicines in the management of long-term conditions can lead to intentional non-
adherence with medication. 
• The patient/ prescriber consultation can provide opportunities for the adoption of 
shared decision making and exploration of the older persons’ beliefs, views and 
experiences of medication taking and how they impact on their medication 
adherence patterns. 
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Introduction 
 
Medication taking behaviour relates to the manner in which an individual adheres to a 
medication regimen. In the older person, it is known that alterations in medication taking 
behaviour can happen and can lead to suboptimal clinical responses to medication and the 
onset of psychological and medical complications as a consequence of poor therapeutic 
control (McElnay, 2005,  Pound et al. 2005). Altered medication taking behaviour can 
reduce the patient’s quality of life and create a financial burden due to the inappropriate 
use of valuable resources (Pound et al., 2005a).  Findings from a recent meta–analysis of 
randomized controlled trials revealed that roughly 20% to 50% of patients mismanage 
their medicines (Kripalani et al., 2007).   
 
The concept of adherence 
 
The terminology used to describe medication taking behaviour has undergone many 
transitions during the last decade. Initially the term compliance was used to illustrate the 
medication taking behaviour which was then replaced by the term concordance. 
Concordance refers to the “anticipated outcome of the consultation between doctors and 
patients about medicine taking” (Pound et al., 2005 p. 134). It is viewed as successful 
prescribing and medication taking based on the partnership with the patient. The most 
current, fashionable and accepted terminology is adherence. This term describes “the 
extent to which a patient’s behaviour in terms of taking medicines, following diets or 
executing lifestyle changes, coincides with advice given by health care professionals” 
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(McElnay, 2005, p.20). The three terminologies tend to be used interchangeably but are 
incorrectly applied. Adherence can be viewed as the central aim, concordance is the 
process used to apply the aim and compliance is the outcome of the process.   
 
Three key health related reports have been used to raise the profile of adherence to 
medication and medication taking behaviour. The Government funded medicines 
partnership which aims to raise the profile of financial and health promotion aspects of 
medication taking and how adherence with medicines can be improved (Carter, Taylor, 
Levenson et al., 2003). The World Health Organization report aims to improve 
medication management in patients with long term conditions particularly in individuals 
who are prone to non-adherent behaviour (World Health Organization, 2003). The recent 
report by the World Health Organisation (2003) suggest that medication taking behaviour 
can be adversely influenced by social, economic, health and therapy related factors and 
patient-specific issues which may be influential such as stress, treatment anxieties, 
perceptions about their illness, need for treatment and essential therapeutic requirements. 
Thirdly, the King’s Fund report (Harrison, 2003) places emphasis on the dominance of 
therapeutic drug related interventions to manage medical conditions and drug dependent 
health care systems that limits the use of alternative and behavioural therapies and public 
health interventions may be more beneficial to patients. 
 
Medication taking behaviour research  
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The vast majority of research that has investigated medication taking behaviour has 
centred on clinical trials and quantitative approaches which includes a paucity of 
qualitative studies (Benson and Britten, 2002). Over the last three decades, more than 200 
variables have been identified that are pertinent to the extent and determinants of 
compliance with medication, few studies since the 1980s have successfully illustrated the 
predictability of adherence (Vermiere et al., 2001). Reported studies have been of 
variable methodological quality, fragmented, lacked a theoretical framework and 
provided limited insights into the continual comprehension of the concept of adherence. 
There is a paucity of qualitative studies that have investigated the patients’ views on 
adherence or lay beliefs about medication taking. Blaxter and Britten (1996) found that 
older people used medicines as a resource to be used as necessary rather than as 
prescribed by the health care provider. Additional lay beliefs on medicine taking include: 
i. The need to reduce the symptoms of hypertension, to feel physically better 
(Kjellgren et al., 1998, Ekman et al., 2006). 
ii. Balancing reservations with perceived benefits of taking medicines 
(Benson and Britten, 2002). 
iii.  Fear of complications and desire to control blood pressure (Svensson et 
al., 2000). 
iv.  Positive experience or confidence in the prescriber (Benson and Britten, 
2006).  
 
Even though 45% of all medications prescribed in the UK are for older people, it is 
postulated that up to 50% of older people are non-compliant with their medication (SCIE, 
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2005). There is also a paucity of qualitative research that has focused on this client group 
and their medication taking behaviour. 
 
The focus of this paper is to address medication taking behaviour in older people. Older 
people were preferentially selected for several reasons. First, older people are highly 
likely to suffer from multiple diseases (Hughes, 2004). Second, older people frequently 
administer three or more medicines concurrently to manage these conditions and third as 
a result of polypharmacy, older people are increasingly likely to mismanage their 
medicines (Corlett, 1996). Medication mismanagement is a significant problem as it can 
lead to poor control of chronic conditions such as hypertension (Mancia et al., 1997, 
Benson and Britten, 2002), heart failure (Cline et al., 1999, Struthers et al., 1999) and 
cholesterol management (Senior, et al., 2004). Up to two thirds of patients have poor 
blood pressure control due to failure to adhere to anti hypertensive medication; resulting 
in complications and unplanned admission to hospital (Chin and Goldman, 1997). 
 
This literature review aims to present the evidence from quantitative and qualitative 
studies that examined beliefs, attitudes and views pertinent to medication taking 
behaviour in individuals over the age of 65 years. 
 
Method 
This review was restricted to a review of the current literature and draws on established 
methods (CRD, 2001). This review of the literature provides an evaluation of the range of 
existing research relevant to adherence with medication in older people. However, the 
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aim of this review is not to evaluate the quality of the studies reported but to provide a 
succinct account of the range of existing studies and literature relevant to the subject of 
medication adherence and older people (Mays et al., 2001). This report of a scoping 
exercise provides an illustration of the published research studies and literature specific to 
older people and their beliefs, perceptions and views relevant to adherence with 
medication from the early 1990’s to the present time. The study drew on both UK based 
and international literature in an attempt to illuminate the complexity and depth of the 
subject and to illustrate the global nature of the subject matter.   
 
The search strategy employed the following data bases: Pubmed, Cinahl, Google scholar, 
advanced Google scholar, Medline, Medicines Partnership, The Cochrane Library, The 
King’s Fund, RCN database and the World Health Organisation.  In addition to trawling a 
range of relevant electronic databases for literature, hand searching of individual journals 
which could supply additional literature was also undertaken. A defined search strategy 
was undertaken using the following terms: medication taking behaviour, adherence with 
medication, older people, elderly people, medication review, medication management, 
perceptions of medicines, health beliefs and medicines, values and medicines, medication 
management in combination. References were selected from a ten year period from 1997 
until 2007, as it was believed that most relevant studies would be found within this 
period.  
 
Research studies were included in the review if they addressed the central question what 
are older people’s beliefs, attitudes and views pertinent to medication taking behaviour ? 
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In addition to research studies, reviews and opinion papers pertinent to the subject area 
were also included in the scoping exercise. Policy papers, theses, book reviews and 
textbooks were excluded from the scoping exercise. 
 
In total 552 references were identified electronically, and by hand searching. Titles and 
abstracts were scanned for relevance. Over 100 reports were read in detail, and of these 
30 research studies emerged that were relevant to older people and adherence to 
medication (Table 1). Reasons for the exclusion of articles included the following: age 
groups younger than 65 years of age, included a mixture of age groups, focused on 
medication adherence interventions, drug related study that was not focused on adherence 
with medication and those that used electronic measures of adherence as these are of 
variable quality.  
 
Papers were appraised using a version of the Critical Appraisal Skills Programme 
(Critical Appraisal Skills Programme, 1998). Using this method, studies were excluded if 
they were judged to be insufficiently focused on medication adherence or did not focus 
specifically on older people. The design of studies included in this exercise varied from 
cross sectional and questionnaire surveys, community based cohort studies, systematic 
reviews of randomized controlled trials, prevalence studies, small scale exploratory 
studies, and a range of exploratory qualitative studies using discourse analysis, grounded 
theory and phenomenological study designs.  
 
 9
A narrative synthesis of the evidence was undertaken. This allowed an analysis of studies 
in order to make subjective judgements about the extent to which the body of evidence 
addressed the key aim of the review.  This analysis did not seek to examine the 
heterogeneity of studies or to describe the quality and rigour of the study designs 
employed but aimed to draw on the salient findings and merit of the individual studies 
and their contribution to the subject area in order to present an overview of the existing 
research.  
 
  
Findings 
Four themes emerged from the findings of the studies reviewed. These include: the 
experience of adherence, perceptions and attitudes to medication adherence and non-
adherence, patients’ acceptance of their illness and impact on medication taking 
behaviour, and disease specific information.  
 
The experience of adherence 
Adherence with medication can be considered as a coping strategy used by patients in 
response to a chronic illness. Within this strategy patients may identify their perceptions 
of illness and how they self manage the condition (Leventhal, 1992).  Illness perception 
can be influenced by issues of disease aetiology and duration, control or cure and its 
consequences, all of which can impact on adherence with medication. Sackett et al (1979) 
reported that adherence rates for prescribed medication can vary from 0% to 50%. This 
position has remained unchanged since early 1970s (Vermiere et al., 2001). Several 
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reasons attest to why older people fail to adhere to prescribed medication regimens. Sale 
et al., (2006) reported that older people were fearful of becoming addicted to their 
medication, especially to codeine based analgesics. As a result, older people rationalized 
the administration of medicines usually at the lowest possible dose rather than the 
required dose. Pain relief was viewed as a last resort to pain management. The resulting 
pain endurance had a negative effect on mobility and activity. Medication rationalization 
is not unusual for older people. These findings concur with studies examining 
bisphosphonate therapy (Carr et al., 2006) and vitamin D preparations in osteoporosis 
patients (Zafran et al., 2005), and antihypertensive medication in hypertensive patients 
(Benson & Britten 2002; 2006). All three studies indicate that patient’s responses were a 
reflection of individual perceptions of their illness and role of medication in its 
management. 
 
Adherence to medication regimens can be dependent on age. People over the age of 75 
years take more medicines than people 65-74 years age group (OR= 1.69, 1.54-1.85) 
(Chen et al., 2001). There are numerous adherence risk factors, these include the 
following: 
• Cognitive impairment (OR =2.0, 1.4.-2.8)  (Salas et al., 2001) 
• Health literacy (Roth & Ivey, 2005) 
• Inability to manage medication regimens (Griffiths et al., 2004) 
• Lifestyle changes caused by social events, long distance travel which often resulted in    
tablets rattling in dosett boxes (Svensson et al., 2000, Kippen et al., 2005) 
•  Embarrassing and unpleasant medication side effects (Kippen  et al., 1999). 
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Perceptions and attitudes to medication adherence and non-adherence  
The concept of adherence and non-adherence with medication has been extensively 
investigated (Bonner & Carr, 2002, Campbell et al., 2003, Ekman et al., 2006, Kjellgren 
et al. 1995, Phatak and Thomas, 2006, Roth & Ivey, 2005, Van der Wal et al., 2005). 
Figure 1 illustrates the common perceptions and characteristics of adherent and non-
adherent medication taking behaviour. 
 
Adherent medication taking behaviour focuses on either purposeful or patterned 
adherence to medication regimens. Both types are enforced and contingent on the 
practicalities of taking the medicine. Elderly patients can reinforce adherence with the 
use of pill boxes, pouches and pockets specifically used for medicines. This reinforces 
the usefulness of measures such as pill counting and electronic monitoring; these have 
been used previously to evaluate adherence with antihypertensive medication (Lee et al., 
1996, Mallion et al., 1998). 
In terms of non-adherence with medication, two distinct patterns are proposed: 
purposeful or intentional non-adherence and accidental or unintentional non-adherence. 
Both types relate to the lack of an established pattern of medication taking which led to 
the incidental omission of medicines (Johnson et al., 1999) and may be experienced 
concurrently. 
 
Patient’s beliefs about medication taking may be based on past experience with 
medicines, and the long-term risks of medicine (Benson and Britten, 2002) such as drug 
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related memory loss and dizziness (Lumme-Sandt et al., 2000). Also the recognition of 
adverse effects (Conrad, 1985, Lumme-Sandt et al., 2000, Hughes, 2004, Maidment et 
al., 2002, Kippen et al., 2005). The anticipation of drug–related side effects and general 
dislike of taking medicines are common causes of intentional non-adherence (Lumme-
Sandt et al., 2000). Some patients relayed their medication taking practices and fears to 
physicians that resulted in appropriate interventions such as additional explanation of the 
medicines involved, a change of medication or dosing intervals (Butler et al., 2002). 
However what is apparent is the indifference or passivity shown by patients, the lack of 
supervision from prescribers and the deficient comprehension of the health dangers of 
continually altering medication regimens. Also relevant are impressions of well being and 
being in control (Campbell et al., 2003). 
The perception of risk related to an illness also correlates with intentional non-adherence 
with medication. Unson et al., (2003) found that older women administering prophylactic 
osteoporosis medication titrated their medication administration in relation to the 
necessity of treatment, potential side effects, risk of fracture and the purchase of 
affordable alternatives. Non-adherence patterns in older people also revolved around 
issues related to perceived drug benefit, drug safety and efficacy, preventative capacity or 
ability to improve health status (Johnson et al., 1999, Benson and Britten, 2002).   
Non-intentional non-adherence is proposed to be range from a random departure to 
medication omissions from a prescribed treatment regimen (Johnson et al., 1999, 
Svensson et al., 2000). The salient features of non-intentional  non-adherence focus on 
altering medication contingent on self assessment or perceptions of mental health, stress 
or anxiety, being asymptomatic and not requiring medication, forgetting to take 
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medicines or simply altering the doses of medicines to fit in with daily chores. Older 
people adherent with their medication often link the administration of medication to 
specific lifestyle events, time, location and patterns of daily activities (Svensson et al., 
2000, Kippen, et al., 2005).  
 
Patient acceptance of their illness and impact on medication taking behaviour 
 
It is known that a patient’s past experience of medication taking can adversely affect their 
adherence to medication (De Geest et al.,1998, Scotto, 2005) and can lead to 
rationalization of medicines (Benson and Britten, 2002;2006). This response is often 
related to deficient comprehension of the role of medicines in illness management and 
deficient acceptance of their illness (Phatak and Thomas, 2006). It is therefore essential  
that patients stop trivializing the importance of the condition, the symbolic role that 
medication plays in the management of the symptoms of that condition and address 
altering identities and the personal challenges of taking medicines (Dowell and Hudson, 
1997).  
  
The older individual’s innate decision-making processes can influence adherence to 
medication. Three phases are proposed; patient knowledge about the illness and 
treatment; testing of medicines and medication taking behaviour (Dowell and Hudson 
(1997). First, faith in the prescribers’ ability to correctly diagnose and manage their 
illness is paramount (Levy and Feld, 1999, Dunbar-Jacob et al., 2000, Unson et al., 
2003).  Second, involves testing the clinical effectiveness and side effects of medicines is 
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often undertaken and usually involves omitting or discontinuing medicines before 
developing a regular adherence pattern and fully accepting the need for medicines 
(Dowell and Hudson 1997). Side effects may be viewed as positively ‘harmful’ and 
worse than the medical condition. So the perceived benefits need to outweigh the risk of 
side effects and all new medicines need to be carefully explained (Barber et al., 2004). 
 
The third aspect of medication taking behaviour relates to the acceptance of an illness 
(Scotto, 2005). Three groups of users are described. Passive users adhere to their 
prescribed medication and usually do not question the need for medicines whereas active 
users adjust their medicine intake according to their personal needs. The third group is 
classified as rejectors as they usually fail to adhere to their medication regimen (Dowell 
and Hudson, 1997). By exploring older people’s views and potential misconceptions 
about their illness, prescribers can assess their willingness to adhere to medication 
regimens that are important to successful medication management.  
 
Shared decision making 
 
The patient consultation should take the form of a friendly, open discussion that provides 
opportunities for patients to ask questions abut their illness and prescribed medicines but 
this is often not the case (Watson et al., 1998).  During consultation, older people need to 
be able to engage in shared medication–specific decision making in a language that the 
older person can relate to (Veehof et al., 1999, Belcher et al., 2006). These aspects are 
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contingent on the appropriate medication management of older people (Svensson et al., 
2000, Benson and Britten, 2002).  
 
Older people were often confused by incomplete and unclear instructions. For example, 
patients were told to take a medicine at a particular time of the day with no 
comprehension of what could occur if they failed to adhere to the instruction or 
administered their medicines when they were out of date. Or being advised not to drink 
grapefruit juice with medicines but not knowing whether this related to a glass or a bottle 
of juice. There were also discrepancies in the information provided by different health 
care practitioners. This led to confusion for patients (Kippen et al., 2005). 
  
 
Discussion 
 
Adherence to medication is an important aspect of medication management of long-term 
conditions particularly in older people and is a growing area of research. In the research 
available, there is a tendency to propose that the older person should be passive and not 
question medical decisions and that health will improve if they adhere to prescribed 
medication regimen. This assumption is based on a paternalistic approach to medication 
mamagement. Prescribers should adopt a consultation style that encourages patient 
participation and the sharing of views that address the patient’s perspective and health 
beliefs. By employing shared decision making strategies the patient perspectives on 
illness and medicines, particularly new medicines used to treat chronic conditions can be 
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explored. In addition, both short-term and long-term goals can be negotiated (Belcher et 
al., 2006). By endeavoring to take this approach to the consultation it may increase 
patient confidence in the prescriber. In this way patients may feel able to voice their 
concerns about medicines and improve intentional adherence patterns (Barber et al., 
2004, Maidment et al, 2002, Belcher et al., 2006). In this respect the nurses with 
prescribing roles can play a pivotal role and make a significant impact on the lives of 
older people through structured medication assessment and education (Griffiths et al., 
2004). It is acknowledged that the elderly need to be treated as a special group with more 
attention provided to ensure that they not only understand the need for medicines but also 
the role that medicines play in the management of their condition (Butler et al., 2002).   
 
Recent evidence form randomized controlled trials infers that adherence with medication 
can improve through reduced dosing demands and education (Kripalani et al., 2007). 
Although randomized controlled trials are useful, numerous research studies provide 
inconsistent results which may be due to the lack of theoretical framework to measure 
adherence-enhancing methods and the fact that there is no gold standard for measuring 
adherence with medication. Improvements are needed with regard to the quality of 
studies and the use of quality indicators (Vermiere et al., 2001). There needs to be more 
emphasis on adherence to medication rather than compliance with medication as 
adherence more fully addresses lifestyle and medication taking behaviour. More 
qualitative research is needed as these research approaches help to contextualize evidence 
from clinical trials. Future adherence research should aim to investigate the patient’s 
perspective on the perceived benefits of medication, difference between the patient’s and 
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the prescribers  perceived risk, experience of drug administration, innate motivation to 
adhere to medication regimens, and also the historical and social context of medication 
taking behaviour. 
 
The aim of this literature review was exploratory in that it aimed to present the evidence 
from quantitative and qualitative studies that examined beliefs, attitudes and views 
pertinent to medication taking behaviour in the older person.  There were limitations of 
this review. It did not permit a full exploration of design of studies, including description 
of the study sample, description of the studies involved, an evaluation of the size of 
effects across studies, and also an assessment of the factors that may limit the 
generalisability of the results of the review.  
 
 Conclusion 
Medication taking behaviour in older people is a complex issue that can have significant 
financial and health related consequences. It is an area of research that has been 
investigated in relation to the use of nursing interventions and prevalence but future 
research needs to be more patient centered to elucidate the patient’s perspective and 
possible impact of a shared approach to clinical decision making. Further, the generation 
of a measure to assess risk of non-adherence with medication would be an important 
contribution of future research and development in nursing. 
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